Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.3389/fmicb.2019.00190 |
Resumo: | This work was funded by a Research Grant 2018 of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grant PTDC/BIA-MIC/31233/2017 awarded to MC. |
id |
RCAP_9a4c4fc1fc73dac625fb5b252d2bc4b3 |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/81794 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesisAntibiotic resistanceCell wallMycobacteriaMycobacteriophage lysis enzymesPeptidoglycanTuberculosisβ-lactamsMicrobiologyMicrobiology (medical)SDG 3 - Good Health and Well-beingThis work was funded by a Research Grant 2018 of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grant PTDC/BIA-MIC/31233/2017 awarded to MC.Tuberculosis (TB), which is caused by Mycobacterium tuberculosis (Mtb), is one of the leading cause of death by an infectious diseases. The biosynthesis of the mycobacterial cell wall (CW) is an area of increasing research significance, as numerous antibiotics used to treat TB target biosynthesis pathways of essential CW components. The main feature of the mycobacterial cell envelope is an intricate structure, the mycolyl-arabinogalactan-peptidoglycan (mAGP) complex responsible for its innate resistance to many commonly used antibiotics and involved in virulence. A hallmark of mAGP is its unusual peptidoglycan (PG) layer, which has subtleties that play a key role in virulence by enabling pathogenic species to survive inside the host and resist antibiotic pressure. This dynamic and essential structure is not a target of currently used therapeutics as Mtb is considered naturally resistant to most β-lactam antibiotics due to a highly active β-lactamase (BlaC) that efficiently hydrolyses many β-lactam drugs to render them ineffective. The emergence of multidrug- and extensive drug-resistant strains to the available antibiotics has become a serious health threat, places an immense burden on health care systems, and poses particular therapeutic challenges. Therefore, it is crucial to explore additional Mtb vulnerabilities that can be used to combat TB. Remodeling PG enzymes that catalyze biosynthesis and recycling of the PG are essential to the viability of Mtb and are therefore attractive targets for novel antibiotics research. This article reviews PG as an alternative antibiotic target for TB treatment, how Mtb has developed resistance to currently available antibiotics directed to PG biosynthesis, and the potential of targeting this essential structure to tackle TB by attacking alternative enzymatic activities involved in Mtb PG modifications and metabolism.DCV - Departamento de Ciências da VidaUCIBIO - Applied Molecular Biosciences UnitInstituto de Tecnologia Química e Biológica António Xavier (ITQB)RUNCatalão, Maria JoãoFilipe, Sérgio R.Pimentel, Madalena2019-09-19T22:37:20Z2019-02-112019-02-11T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.3389/fmicb.2019.00190eng1664-302XPURE: 13570721http://www.scopus.com/inward/record.url?scp=85065905919&partnerID=8YFLogxKhttps://doi.org/10.3389/fmicb.2019.00190info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T04:36:26Zoai:run.unl.pt:10362/81794Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:36:08.624705Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
title |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
spellingShingle |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis Catalão, Maria João Antibiotic resistance Cell wall Mycobacteria Mycobacteriophage lysis enzymes Peptidoglycan Tuberculosis β-lactams Microbiology Microbiology (medical) SDG 3 - Good Health and Well-being |
title_short |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
title_full |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
title_fullStr |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
title_full_unstemmed |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
title_sort |
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis |
author |
Catalão, Maria João |
author_facet |
Catalão, Maria João Filipe, Sérgio R. Pimentel, Madalena |
author_role |
author |
author2 |
Filipe, Sérgio R. Pimentel, Madalena |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
DCV - Departamento de Ciências da Vida UCIBIO - Applied Molecular Biosciences Unit Instituto de Tecnologia Química e Biológica António Xavier (ITQB) RUN |
dc.contributor.author.fl_str_mv |
Catalão, Maria João Filipe, Sérgio R. Pimentel, Madalena |
dc.subject.por.fl_str_mv |
Antibiotic resistance Cell wall Mycobacteria Mycobacteriophage lysis enzymes Peptidoglycan Tuberculosis β-lactams Microbiology Microbiology (medical) SDG 3 - Good Health and Well-being |
topic |
Antibiotic resistance Cell wall Mycobacteria Mycobacteriophage lysis enzymes Peptidoglycan Tuberculosis β-lactams Microbiology Microbiology (medical) SDG 3 - Good Health and Well-being |
description |
This work was funded by a Research Grant 2018 of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grant PTDC/BIA-MIC/31233/2017 awarded to MC. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-09-19T22:37:20Z 2019-02-11 2019-02-11T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.3389/fmicb.2019.00190 |
url |
https://doi.org/10.3389/fmicb.2019.00190 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
1664-302X PURE: 13570721 http://www.scopus.com/inward/record.url?scp=85065905919&partnerID=8YFLogxK https://doi.org/10.3389/fmicb.2019.00190 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137980655337472 |